Prediabetes may be a weak indicator of risk for diabetes among older adults
1. Older adults with prediabetes were more likely to regress to normoglycemia or pass away than progress to diabetes.
2. Prediabetes may be a weak...
Long-term usage of cyproterone acetate (CPA) at high doses associated with greater risk of...
1. Long-term usage of cyproterone acetate (CPA) at high doses was associated with greater risk of meningioma development in females.
2. Discontinuation of CPA after...
Māori and Pacific New Zealanders may be disproportionately affected by type 2 diabetes-related clinical...
1. Compared to patients of European descent, poorer health outcomes were seen among Māori and Pacific New Zealanders with type 2 diabetes.
2. Māori patients...
Metabolic surgery may be more effective than medical therapy for long-term control of type...
1. 10-year remission rates were significantly higher for Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion (BPD) than medical therapy.
2. Patients in the BPD and...
Novel hybrid closed-loop system improves glycemic control in young adults with type 1 diabetes...
1. Participants using the novel advanced hybrid insulin delivery system (Medtronic) had a greater proportion of time spent in their target glucose range versus...
Gaps in evidence-based therapy use in patients with type 2 diabetes mellitus and atherosclerotic...
1. Significant gaps were found in the use of evidence-based therapies in insured patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus.
Evidence Rating...
High fasting insulin levels in children associated with higher rates of psychosis and psychotic...
1. Persistently high fasting insulin levels were associated with psychosis and psychotic disorder later in life.
2. Major increases in body mass index during puberty...
Sotagliflozin reduces cardiovascular risk for patients with diabetes and worsening heart failure
1. Sotagliflozin was shown to lower the risk of total number of deaths from cardiovascular causes and hospitalizations and urgent visits for heart failure...
Golimumab effective at preserving insulin production in type 1 diabetes
1. In this randomized, double-blind, phase two trial, the use of golimumab led to more C-peptide production, indicative of improved endogenous function, compared to...
No mortality benefit found for in-home glucose-lowering medications among those with COVID-19
1. In-home glucose-lowering medications were not associated with increased mortality or complications among those with COVID-19.
Evidence Rating Level: 2 (Good)
Diabetes is one of the...
